Most healthcare providers recommend that semaglutide users consume at least 1,200 to 1,500 calories daily for women and 1,500 to 1,800 for men, even when appetite is minimal
Abstract Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option
26% of study participants regained 25 to 99% of their lost weight
This caloric deficit, rather than an increase in metabolic rate, is the main driver of weight loss observed in clinical trials
Is tirzepatide insomnia worse at higher doses
The optimal timing for fasting from clear liquids alone is unclear because all the included studies also had patients consuming solids